PGNY is expected to report earnings to fall 64.00% to 14 cents per share on March 03
Q4'24
Est.
$0.14
Q3'24
Beat
by $0.26
Q2'24
Beat
by $0.26
Q1'24
Beat
by $0.26
Q4'23
Beat
by $0.22
The last earnings report on November 12 showed earnings per share of 40 cents, beating the estimate of 14 cents. With 2.23M shares outstanding, the current market capitalization sits at 3.52B.
a medical device company, which engages in the field of reproductive medicine, translating scientific discoveries related to early embryo development into clinical tools